EI
CVS icon

Ethic Inc’s CVS Health CVS Stock Holding History

Ethic Inc’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.69M Buy
45,334
+3,266
+8% +$292K 0.06% 318
2026
Q1 		$3.02M Buy
42,068
+1,785
+4% +$138K 0.05% 362
2025
Q4 		$3.2M Buy
40,283
+2,096
+5% +$165K 0.05% 358
2025
Q3 		$2.88M Buy
38,187
+4,636
+14% +$318K 0.05% 377
2025
Q2 		$2.3M Buy
33,551
+505
+2% +$33.1K 0.04% 395
2025
Q1 		$2.25M Sell
33,046
-15,951
-33% -$955K 0.05% 385
2024
Q4 		$2.2M Sell
48,997
-15,035
-23% -$843K 0.04% 396
2024
Q3 		$5.11M Buy
64,032
+9,578
+18% +$559K 0.13% 188
2024
Q2 		$3.22M Sell
54,454
-9,578
-15% -$599K 0.08% 275
2024
Q1 		$5.11M Buy
64,032
+4,642
+8% +$355K 0.13% 188
2023
Q4 		$4.69M Buy
59,390
+2,656
+5% +$189K 0.14% 179
2023
Q3 		$3.96M Sell
56,734
-4,336
-7% -$307K 0.14% 178
2023
Q2 		$4.22M Sell
61,070
-50,233
-45% -$3.57M 0.16% 158
2023
Q1 		$8.27M Buy
111,303
+66,770
+150% +$5.6M 0.34% 58
2022
Q4 		$4.15M Buy
44,533
+11,359
+34% +$1.1M 0.22% 117
2022
Q3 		$3.16M Sell
33,174
-1,774
-5% -$176K 0.21% 116
2022
Q2 		$3.24M Buy
34,948
+11,731
+51% +$1.14M 0.23% 111
2022
Q1 		$2.35M Sell
23,217
-8,619
-27% -$905K 0.16% 156
2021
Q4 		$3.28M Sell
31,836
-1,710
-5% -$158K 0.25% 97
2021
Q3 		$2.85M Buy
33,546
+13,244
+65% +$1.11M 0.29% 81
2021
Q2 		$1.69M Buy
20,302
+4,195
+26% +$344K 0.21% 121
2021
Q1 		$1.21M Sell
16,107
-823
-5% -$59.9K 0.22% 118
2020
Q4 		$1.16M Buy
16,930
+3,838
+29% +$250K 0.31% 80
2020
Q3 		$765K Buy
13,092
+1,719
+15% +$107K 0.29% 91
2020
Q2 		$739K Buy
11,373
+1,645
+17% +$104K 0.42% 57
2020
Q1 		$577K Buy
9,728
+1,072
+12% +$71.6K 0.48% 59
2019
Q4 		$643K Buy
+8,656
New +$608K 0.47% 64

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Ethic Inc's CVS Position: Q2 2026 in Review

Ethic Inc increased its CVS Health (CVS) stake by 7.8% in Q2 2026, buying an estimated $292K and bringing the position to 45,334 shares worth $4.69M. The position accounts for 0.06% of the portfolio, ranked #318.

Ethic Inc first reported a position in CVS in Q4 2019 and has held it in 27 quarters since. The position peaked at $8.27M in Q1 2023. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Ethic Inc held 45,334 shares of CVS Health worth $4.69M as of Q2 2026.
  • Ethic Inc bought 3,266 CVS Health shares in Q2 2026, an estimated $292K.
  • CVS Health made up 0.06% of Ethic Inc's portfolio in Q2 2026, its #318 holding.
  • Ethic Inc first reported a position in CVS Health in Q4 2019 and has held it in 27 quarters since.
  • Ethic Inc's CVS Health position peaked at $8.27M in Q1 2023.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.